A painful but common condition in older adults is shingles or herpes zoster. I’ve known several elderly people afflicted with this, and I will absolutely get the vaccine as soon as I turn 60!
The vaccine, Zostavax, is FDA-approved for ages 50 and up, but the Cleveland Clinic recently advised that it’s not cost effective for anyone under 60 to get immunized.
Why? Because Zostavax is too expensive. On … read on
It’s not too late to give the Food and Drug Administration (FDA) your opinion on its latest effort to require that more information be provided on food labels.
Last year, food labels began listing the amount of added sugar per serving (usually listed in grams).
Now the FDA proposes that labels also show sugar as a percentage of the recommended daily intake or value (%DV). Labels already do this for … read on
It’s almost that time of year when insurance companies start sending out information about next year’s plans and what may or may not have changed in their policies, such as premiums and benefits.
A little-known new rule of the Affordable Care Act (ACA) will take effect on January 1, 2016, and might affect your health insurance plan and health care costs.
Specifically, this rule takes away what’s been called … read on
I’ve posted before about how expensive it is to be treated for cancer.
Recently, a patient posted on the health blog KevinMD about her experience dealing with not only the stress of metastatic ovarian cancer, but the struggle to stay afloat financially.
I am one of many people today “living” with cancer. I want to focus on the impact cancer has on my personal finances, and this is probably
… read on
Have you ever felt that going to see your physician or going to the hospital is like stepping onto an assembly line?
Well, the metaphor of being a car (or a hamburger) is a pretty accurate one. Two articles I read this week discuss how health care leaders have been turning to the big manufacturers—Toyota, for example—to increase efficiency, production and profits.
Kaiser Health News (KHN) puts a positive spin … read on
Two big health insurance mergers are in the works: Aetna plans to buy Humana for $33 billion, and Anthem will take over Cigna for a whopping $54.2 billion.
The number of major health insurers in the US will soon be three, down from five.
So much for more competition, huh?
What’s happening in the health care delivery system mirrors the insurance industry. The biggest health care corporations are furiously buying … read on
“Cover-your-ass health care” or “save-my-ass medicine” are terms used to describe all the extra diagnostic tests (blood tests, CT scans, MRIs, etc.) ordered by physicians to rule out possible (but unlikely) life-threatening conditions.
Such as going to the emergency department with a headache and getting a CT scan to rule out an aneurysm or a brain tumor.
Or, as in this video example, being worked up for a heart attack … read on
Two recent stories from Kaiser Health News caught my attention because they underscore the burden placed on patients to understand exactly what services their health insurance does or doesn’t cover.
Of course everyone should know their health plan’s benefits, but with so many different types of plans, … read on
This week the National Kidney Foundation (NKF) started a public health campaign called “Everybody Pees.”
The highlight is a short video featuring a catchy song and colorful South Park-esque kidneys peeing in all sorts of places—parks, swimming pools, on top of a car, etc.
OK, it’s cute, kind of. But here’s my problem with this video (other than the it’s a cartoon more appropriate for … read on
High drugs costs are one of the leading causes of higher health care costs overall. Not only are more people taking prescription drugs than ever before, the drugs are getting more and more expensive.
That’s why it’s so infuriating to read about drug companies using “devious” tactics to make sure their profitable blockbuster drugs can evade competition from the less expensive generics (although even many generic drugs are skyrocketing in … read on